Imagion Biosystems (ASX: IBX) has received positive results on dosage tests in preparation for a Phase 2 clinical trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback